Blog / Archives
Green Day with Rayno Biopharmaceutical Stocks Up >2%
Some Huge Moves Today Brings Hope For Summer Rally ETFs Up: FBT $83 up 2.58%, IBB $254.78 up 1.14%, XBI $148.9 up 3.28%. Rayno Large Cap Portfolio: up 14,4% YTD with Biogen Idec(BIIB) and Gilead...
Rayno DX and Tools Mid Year Review and AACC Update: ABAX, ILMN, HOLX, TMO.. Update-2
Update -2 Aug. 1 Draft Guidance on LDTs Coming from FDA in 60 Days: Tests Must Be Validated More regulation coming means greater development costs and potential time delays for clinical tests in...
No Summer Doldrums In Biotech Today … PBYI…Update-1
Update 7/23 Biogen Idec (BIIB) Soars 11% on Earnings EPS at $3.49 vs est $2.83; Sales of MS drugs were $2.42B vs $1.72B last year. Our large cap portfolio is now up 15% YTD with less risk than mid...
FED Comments Focus On “Bubble” Stocks In Social Media and Biotech…. Update-1
Update 8PM EDT NASDAQ Holds Losses to 0.54%-Futures Stable Biotech Damage Across the Sector-Rayno Life Science Portfolio Notes Large Caps off about 2% (FBT), but Gilead (GILD) down only 0.95% and...
Tepid Rally Favors Large Caps: ABBV, GILD, RHHBY
Healthcare Stocks trail other sectors up 0.34%, Energy up 0.8%, Financials up 0.73% and Technology up 0.77% But biotech ETFs are in the Green Biotechnology stocks were mixed today with the...
Risk Off: Take Profits in Biotech Stocks… Update -1
Re-iterate call from Tuesday....futures down 0.8%-Russell down 2%, gold up, Japan and Europe down.. Bad Tape Yesterday (7/7) Calls For Raising Cash NASDAQ at 4451 up 6.58% YTD Major ETFs and...
Rayno Life Sciences: First Half Stock Performance Part 2-ILMN, SQNM
Rayno Diagnostics and Tools-Sequencing Rules Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that...
Rayno Life Sciences: First Half Stock Performance Part I-ACHN, AMRI, VRTX
Biopharmaceutical Stocks Come Roaring Back After Q1 Correction Most Stocks Bottomed in April -We are Currently in Rally Mode The biotech sector is up 18% YTD as tracked by most popular ETFs...
ETFs Outperformed Managed Biotechnology Funds YTD-FBT Is the Leader
2014 YTD- ETFs Outperformed Managed Funds In Biotech In the past managed life science funds outperformed ETFs but this has reversed in 2014. Fidelity's flagship Select Biotechnology Portfolio...
Rayno Diagnostics and Tools Stocks: GHDX, ILMN, QGEN, RGDX.
Rayno Life Science Stocks Focused on Genetic Tests and Biomarkers We have been writing about molecular diagnostics and tools stocks for over 5 years. Here is the summary of our Portfolio. Yesterday...